Metabolic Syndrome, Adiponectin, and Cardiovascular Risk in Spain (The Segovia Study): Impact of Consensus Societies Criteria

Anchuelo, Arturo Corbatón; Martı́nez-Larrad, Marı́a Teresa; Fernández-Pérez, Cristina; Vega-Quiroga, Saturio; Ibarra-Rueda, José María; Serrano-Rı́os, Manuel

doi:10.1089/met.2012.0115

Cited by 20 publications

(16 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to a meta-analysis by Kastorini et al 8 , the MS occurrence in the world according to the IDF definition ranges from about 7.4% to about 50%. In Western countries, the prevalence of the MS according to the IDF definition is lower comparing to the results of our research, ranging from 20% to 30% (for example in Spain, 24.3%) 9 .…”

Section: Discussioncontrasting

confidence: 93%

Prevalence of metabolic syndrome and the association with sociodemographic characteristics in adult population of Banja Luka

2018

View full text Add to dashboard Cite

Background/Aim. Metabolic syndrome (MS) is a cluster of metabolic and hemodynamic disorders that increase the risk of developing atherosclerotic cardiovascular diseases and type 2 diabetes mellitus. The aim of this study was to determine the prevalence of MS and its components in adult population of Banja Luka and association with sociodemographic characteristics. Methods. A total of 685 participants (348 men and 337 women), aged 18 years and over, were analyzed. The diagnosis of the MS was based on definition set by the International Diabetes Federation (IDF). Results. The prevalence of the MS was high (37.5%), slightly higher in women (38.3%) than in men (36.8%), but without statistically significant difference (p = 0.686). Prevalence of each individual component of the MS in the study group was over 30% (systolic blood pressure ≥ 130 mmHg-42.0%; diastolic blood pressure ≥ 85 mmHg-31.0%; triglycerides ≥ 1.7 mmol/L-36.1%; high density lipoprotein (HDL) cholesterol ˂ 1.03 for men and ˂ 1.29 for women-31.2%; glucose ≥ 5.6 mmol/L-32.8%; central obesity ≥ 94 cm male and ≥ 80 cm female-62.6%). The prevalence of the MS was not associated with gender, but with age. A number of participants increased with incresed age in the group with the MS with statistically significant difference compared to the group without the MS. The study showed an association between level of education and the MS. Low level of education was associated with the appearance of the MS with statistically significant differences (df = 3; p = 0.013). Association between level of education and the MS was shown in women (df = 3; p = 0.000), but not in men (df = 3; p = 0.883). Retirees and housewives were significantly present in the group with the MS, students and unemployed in the group without the MS, while employed participants showed no statistically significant difference. Conclusion: The MS was diagnosed in over one-third of adults in Banja Luka. Prevalence of MS was not associated with gender, but it was associated with age, level of education as well as with some categories of employment.

show abstract

Section: Discussioncontrasting

confidence: 93%

Prevalence of metabolic syndrome and the association with sociodemographic characteristics in adult population of Banja Luka

2018

View full text Add to dashboard Cite

show abstract

“…This observed prevalence was slightly higher than the prevalence estimated around the world (between 20% and 25%) [4]. In fact, the mean prevalence of MS in Brazil was higher than that reported in such European countries as Portugal (27.6%) [24], Spain (26.6%) [25], France (25% in males and 15.3% in females) [26] and Italy (28% in males and 26% in females) [27]. It was also higher than in the United States of America (22.9%) [7] and some Latin American countries: Mexico (26.6%) [8] and Peru (18.1%) [10].…”

Section: Discussionmentioning

confidence: 75%

Prevalence of metabolic syndrome in Brazilian adults: a systematic review

et al. 2013

View full text Add to dashboard Cite

BackgroundThe metabolic syndrome (MS) is a complex of risk factors for cardiovascular disease. This syndrome increases the risk of diabetes, cardiovascular disease and all-cause mortality. It has been demonstrated that the prevalence of MS is increasing worldwide. Despite the importance of MS in the context of metabolic and cardiovascular disease, few studies have described the prevalence of MS and its determinants in Latin America. The present study aims to assess studies describing the prevalence of MS in Brazil in order to determine the global prevalence of the syndrome and its components.MethodsSystematic review. Searches were carried out in PubMed and Scielo from the earliest available online indexing year through May 2013. There were no restrictions on language. The search terms used to describe MS were taken from the PubMed (MeSH) dictionary: “metabolic syndrome x”, “prevalence” and “Brazil”. Studies were included if they were cross-sectional, described the prevalence of MS and were conducted in apparently healthy subjects, from the general population, 19-64 years old (adult and middle aged) of both genders. The titles and abstracts of all the articles identified were screened for eligibility.ResultsTen cross-sectional studies were selected. The weighted mean for general prevalence of MS in Brazil was 29.6% (range: 14.9%-65.3%). Half of the studies used the criteria for clinical diagnosis of MS proposed by the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) (2001). The highest prevalence of MS (65.3%) was found in a study conducted in an indigenous population, whereas the lowest prevalence of MS (14.9%) was reported in a rural area. The most frequent MS components were low HDL-cholesterol (59.3%) and hypertension (52.5%).ConclusionsDespite methodological differences among the studies selected, our findings suggested a high prevalence of MS in the Brazilian adult population.

show abstract

“…Other studies conducted in Iran and other parts of the world reported a higher prevalence for MS. The prevalence of this disorder among adults was 38.5% in the United States [9], 27.8% in Spain [32], 21.1% in France [10], 25.9% in Norway [33], 54.8% in Mexico [11], 35.73% in Morocco [2], 30% in Tanzania [34], 25% in Korea [35], 21.3 -39% in China [12,13], 40-50% in India [36], 21% in Saudi Arabia [14], 36.3% in Jordan [37], 33.5% in Turkey [15], and 21.9% -32% in different regions of Iran [16][17][18][19][20][21][22][23]. Possible reasons for this difference and lower prevalence of MS, are racial and regional differences, age differences between studies, and the use of different definitions for MS.…”

Section: Discussionmentioning

confidence: 99%

Metabolic syndrome and its risk factors among middle aged population of Iran, a population based study

Ebrahimi

Emamian

Shariati

et al. 2016

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

Metabolic Syndrome, Adiponectin, and Cardiovascular Risk in Spain (The Segovia Study): Impact of Consensus Societies Criteria

Cited by 20 publications

References 49 publications

Prevalence of metabolic syndrome and the association with sociodemographic characteristics in adult population of Banja Luka

Prevalence of metabolic syndrome and the association with sociodemographic characteristics in adult population of Banja Luka

Prevalence of metabolic syndrome in Brazilian adults: a systematic review

Metabolic syndrome and its risk factors among middle aged population of Iran, a population based study

Contact Info

Product

Resources

About